ScanMed Funding: How Much Did They Raise & Key Investors

How Much Did ScanMed Raise?
Funding & Key Investors

ScanMed has solidified its position in the medical imaging sector, securing a total capital infusion of $785K to accelerate its diagnostic hardware initiatives. This trajectory of financial backing, highlighted by a recent strategic investment of $435K, underscores the market confidence in the company's specialized approach to MRI coil development and refurbishment. By maintaining a robust balance sheet, ScanMed continues to bridge the gap between high-performance clinical requirements and cost-effective hardware lifecycle management.

The firm's ability to attract significant debt financing reflects its operational maturity and the critical nature of its infrastructure within the broader radiology ecosystem. As the company scales its manufacturing capabilities, this capital serves as a vital catalyst for both R&D and the expansion of its proprietary product portfolio.

What is ScanMed?

ScanMed

Manufacturing

Medical Devices & Equipment

Consumer Services

ScanMed operates as a premier OEM-certified developer and manufacturer of advanced MRI coils, distinguished by its commitment to high signal-to-noise ratio (SNR) and clinical versatility. The company's product catalog includes industry-first innovations such as the PROCURE wearable pelvic/prostate coil and the fully flexible Blanket Coil. Beyond original equipment manufacturing, ScanMed maintains its status as the world's largest independently-owned MRI coil repair and refurbishment entity. This dual-model approach allows the firm to leverage deep technical expertise in electromechanical product development to serve both clinical providers and original equipment manufacturers. With ISO 13485 and ISO 9001 compliance, the company provides a comprehensive suite of services ranging from 510(k) production to large-scale component manufacturing, ensuring that diagnostic equipment meets rigorous safety and performance benchmarks.

How much funding has ScanMed raised?

ScanMed has raised a total of $785K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$435K

Debt (2020): $350K with participation from PPP

Debt (2021): $435K led by PPP

Key Investors in ScanMed

PPP

Public-Private Partnership

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for ScanMed?

With the recent influx of capital, ScanMed is positioned to aggressively expand its footprint in the medical imaging market. The strategic roadmap focuses on the commercialization of its latest innovations, including the Interchangeable Pediatric Brain MRI Coil and the Dual-Tuned Lung Coil. By leveraging its flex-space design facility and in-house PhD-led diagnostic team, the company aims to shorten the development cycle for next-generation imaging hardware. Future growth will likely be driven by the integration of advanced software solutions with its existing hardware portfolio, further cementing its role as a critical partner for healthcare institutions seeking to optimize their diagnostic imaging capabilities while managing long-term equipment costs.

See full ScanMed company page

See More Financial Insights